Recent years have witnessed remarkable developments in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://nannieljyz199506.blog5star.com/39383669/novel-therapeutic-targets-in-diabetes-retatrutide-and-trizepatide